ArticleFrontiers in physiology2026
Multimodal skin lesion classification for early cancer diagnosis using deep learning.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- XAI-MedNet: A Next-Generation Explainable AI Framework for Contrast-Enhanced Skin Lesion Classification via Entropy-Controlled Optimization.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Skin cancer, particularly melanoma, is a rapidly spreading and potentially life-threatening disease affecting humans. Melanoma typically begins on the skin's surface before penetrating deeper layers. Early detection significantly improves survival rates, with simple and cost-effective treatments yielding a 96% success rate. Traditional diagnosis methods rely on expert dermatologists, specialized equipment, and invasive biopsies. Deep learning offers advanced solutions for detecting skin cancer earlier and with high accuracy to mitigate costs and assist dermatologists. Deep Convolutional Neural Networks have shown promise in several computer vision tasks, including image classification, prompting their application in dermatology. Methods: This work focuses on leveraging three prominent DCNN architectures, DenseNet 201, VGG16, and InceptionV3, to classify skin lesions using dermoscopic images. The HAM10000 dataset was taken and divided into training and testing sets. The preprocessing methods include image normalization, scaling, and Otsu's binary thresholding segmentation and augmentation techniques were applied. We introduced two fine-tuning approaches. Firstly, the top layers of the base model are retrained. Secondly, retraining the half layers of the base models and additional layers are added to form customized CNN models. We merge these underlying models into an ensemble and hyperparameter tuning to enhance performance. The transparency and interpretability of the model are enhanced by Grad-CAM, which raises the model's dependability for clinical applications. Results and Discussion: Combining DenseNet-201, InceptionV3, and VGG16, the proposed ensemble model outperforms the individual models with a testing accuracy of 97.9%. Additionally, it exhibits a better F1-score, recall, and precision of 99.2%, demonstrating its efficacy in automated skin lesion detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.